Immunocytochemical detection of somatostatin receptors sst1 sst(2A), sst(2B), and sst3 in paraffin-embedded breast cancer tissue using subtype- specific antibodies

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2047-2052

  Schulz, Solveig ^a   Schulz, Stefan ^a   Schmitt, Johannes ^a   Wiborny, Dana ^a   Schmidt, Harald ^a   Olbricht, Sigrid ^a   Weise, Wolfgang ^a   Roessner, Albert ^a   Gramsch, Christian ^b   Höllt, Volker ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Gramsch Laboratories   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; OCTREOTIDE; POLYCLONAL ANTIBODY; PROGESTERONE RECEPTOR; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER TISSUE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANTIBODIES; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARAFFIN EMBEDDING; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER; STAINING AND LABELING;

EID: 17444441370     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lamberts, S. W. J., Krenning, E. P., and Reubi, J-C. The role of somatostatin and its analogs in the diagnosis and treatment of rumors. Endocr. Rev., 12: 450-482, 1991.
2. Kvols, L. K., Moertel, C. G., Cornell, M. J., Schutt, A. J., Rubin, J., and Hahn, R. G. Treatment of the malignant carcinoid syndrome: evaluation of a long-lasting somatostatin analogue. N. Engl. J. Med., 315: 663-666, 1986.
3. Pagliacci, M. C., Tognellini, R., Grignani, F., and Nicoletti, I. Inhibition of human breast cancer cell (Mcf7) growth in vitro by the somatostatin analogue SMS201-995 effects on cell cycle parameters and apoptotic cell death. Endocrinology, 129: 255-256, 1991.
4. Prevost, G., Foehrle, E., Thomas, F., Pihan, I., Veber, N., Starzec, A., and Israel, L. Growth of human breast cancer cells inhibited by the somatostatin analogue BM23014 (somatuline). Endocrinology, 128: 323-330, 1991.
5. Scambia, G., Benedetti Panici, P., Baiocchi, P., Perrone, L., Iacobelli, S., and Mancuso, S. Antiproliferative effects of somatostatin and somatostatin analogue SMS201-995 on three human breast cancer cell lines. J. Cancer Res. Clin. Oncol., 114: 306-308, 1988.
6. Setyono-Han, B., Henkelman, M. S., Foekens, J. A., and Klijn, J. G. M. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res., 47: 1566-1570, 1987.
7. Nelson, J., Cremin, M., and Murphy, R. F. Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and sandostatin. Br. J. Cancer, 59: 739-742, 1989.
8. Weckbecker, G., Liu, R., Tolcsvai, L., and Bruns, Ch. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro. Cancer Res., 52: 4973-4978, 1992.
9. Bell, G. I., and Reisine, T. Molecular biology of somatostatin receptors. Trends Neurosci., 16: 34-38, 1993.
10. Vanetti, M., Kouba, M., Wang, X., Vogt, G., and Höllt, V. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett., 311: 290-294, 1992.
11. Vanetti, M., Vogt, G., and Höllt, V. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Lett., 331: 260-266, 1993.
12. Patel, Y. C., and Srikant, C. B. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology, 135: 2814-2817, 1994.
13. Kubota, A., Yamada, Y., Kagimoto, S., Yasuda, K., Someya, Y., Ihara, Y., Okamoto, Y., Kozasa, T., Seino, S., and Seino, Y. Multiple effector coupling of somatostatin receptor subtype SSTR1. Biochem. Biophys. Res. Commun., 204: 176-186, 1994.
14. Buscail, L., Delesque, N., Esteve, J-P., Saint-Laurent, N., Prats, H., Clerc, P., Robberecht, P., Bell, G. I., Liebow, C., Schally, A. V., Vaysse, N., and Susini, C. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc. Natl. Acad. Sci. USA, 91: 2315-2319, 1994.
15. van Eijck, C. H., Krenning, E. P., Bootsma, A., Oei, H. Y., van Pel, R., Lindemans, J., Jeekel, J., Reubi, J. C., and Lamberts, S. W. Somatostatin-receptor scintigraphy in primary breast cancer. Lancet, 343: 640-643, 1994.
16. Vikic-Topic, S., Raisch, K. P., Kvols, L. K., and Vuk-Pavlovic, S. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J. Clin. Endocrinol. Metab., 80: 2974-2979, 1995.
17. Remmele, W., and Stegner, H. E. Recommendation for uniform definition of an immunoreactive score for immunohistochemical estrogen receptor detection in breast cancer tissue. Pathologe, 8: 138-140, 1987.
18. Adams, J. C. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J. Histochem. Cytochem., 40: 1457-1463, 1992.
19. Merz, H., Malisius, R., Mannweiler, S., Zhou, R., Hartmann, W., Orscheschek, K., Moubayed, P., and Feller, A. C. Immunomax. a maximized immunohistochemical method for the retrieval and enhancement of hidden antigens. Lab. Invest., 73: 149-156, 1995.
20. Dournaud, P., Gu, Y. Z., Schonbrunn, A., Mazella, J., Tannenbaum, G. S., and Beaudet, A. Localization of the somatostatin receptor SST2A in rat brain using a specific anti-peptide antibody. J. Neurosci., 16: 4468-4478, 1996.
21. Schindler, M., Sellers, L. A., Humphrey, P. P. A., Emson, P. C. Immunohistochemical localization of the somatostatin sst2(A) receptor in the rat brain and spinal cord. Neuroscience, 76: 225-240, 1997.
22. 2A in rat spinal cord and dorsal root ganglia. Eur. J. Neurosci., in press, 1998.
23. Kubota, A., Yamada, Y., Kagimoto, S., Shmatsu, A., Imamura, M., Tsuda, K., Imura, H., Seino, S., and Seino, Y. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS201-995 in treatment of human endocrine tumors. J. Clin. Invest., 93: 1321-1325, 1994.
24. Greenman, Y., and Melmed, S. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J. Clin. Endocrinol. Metab., 79: 724-729, 1994.
25. Reubi, J-C., Schaer, J. C., Waser, B., and Mengod, G. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNA in primary human tumors using in situ hybridization. Cancer Res., 54: 3455-3459, 1994.